skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I starting purchasing LSPD last August and I have continued up until late last week. My average price is close to $32.

The question that I have to myself is: Do I double down or hold - I am not interested in selling. I had a full position 30 days ago but it has been reduced by more than 50% this past 30 days.

After rereading your answers, looking at LSPD website and news feeds. I gathered and summarized the information below.

Money in bank - lots - greater than $300 million - NO Debt!
15 years of cash at current spending rate.
Large institutions bought at $37.30.
IPO $16.00

Last quarter financial information.
Revenue was a slight beat at $32.8 million.
Met ebdita projections with a loss of $5.25 million.
Book valve is $2.35.
Growth was above 60% yoy to plus $32 million.
Recurring revenue was growing at 58%.

Institutional investors have 49% of the float, with Caisse owning 37%.
They have business in more than 100 countries.
There will be less restaurants in future, maybe 20% less.
The restaurants that are remaining will be financially stronger and have less competition. They will seek out SaaS that can reduce operating expenses while increasing revenues.
Lightspeed has good management.
It is a long term hold for me - 2 to 5 years - maybe forever.
Lightspeed has less than 0.1% of market, I like growth companies.
Lightspeed retailers grew over six times faster than industry average.
Products by Lightspeed: Retail, eCommerce, OnSite, Restaurant, Delivery and Loyalty. Also Lightspeed Payments. Rolled out #lightspeedlocal

They recently bought: Gastofix (Germany), Kounta (Asia Pacific), IKentoo (Swiss) and Chronogolf (Montreal),

A few competitors through a google search, of which I don’t know whom will survive due to many reason ( like lack of money): Shopkeep, Revels, Toast POS, Touch Bistro, Sapaad, Cake, Springboard, Square, Vend, Upserve, Lavu, Clover, AccuPOS, Harbourtouch, POSguys, Touchsuite, ) these are some of the top 20.

Strengths: the bank account; they don’t have to worry about paying operating expenses for many years due to its financial strength; significantly more room to grow; Quebec pension company support and Quebec government support; their source of revenue is across the world; good management; the good management will quickly use its financial strength for growth; growth into other areas that have weak or low market share systems.

Weaknesses: their competitors may have deeper pockets and will grow more quickly dwarfing LSPD and the other competitors; no sales people; how much of their current POS businesses will not be in business in 90 days; others?

That being stated I plan on doubling down in the next 4 weeks by buying when stock in under $13.

Am I missing anything?

Clayton
Read Answer Asked by Clayton on April 06, 2020
Q: Any concerns on the departing CEO Andrew Clark selling >$4 million worth of shares in the last few days when the share price has taken such a hit? Especially since he stated in the press release containing his departure news that he 'looks forward to participating in its continued success as a shareholder'. Was there a rule that he needed to maintain 'x' amount of $ in the company via common shares and now he is allowed to sell to reduce his position? Any comments you have would be great.

Thanks
Read Answer Asked by Ken on April 06, 2020
Q: Hi 5iR Team, I know that LSPD is a software development company, that has developed an ecommerce platform so clients can manage inventory, sales, customer needs, etc.. My question is: who exactly are their customers, in particular their largest customers? My concern is if restaurants form a significant part of their customer base then perhaps I should be avoiding LSPD, no matter how much money they are sitting on??
Thanks Team. Cheers, Chris
Read Answer Asked by Chris on April 03, 2020
Q: You mentioned in your report that clients are mostly retailers and restaurants. Is it mainly for very small businesses? If so, is it not much harder to scale since growth and $ per client is somewhat limited.

Is their product for online stores as well or only retail locations?

How do you like management? Since it has voting control I was hoping to see a bigger stake in the company.

I understand it s higher risk. Do you see the stock as a good/great pick for TFSA long term (5 years +)?

Thank you for your comments. I am just tying to add some tech exposure with stong growth to my portfolio.
Read Answer Asked by Pierre on April 03, 2020
Q: First, congrats on passing the 100,000 question mark. This is a remarkable achievement. Well done.
Can subscribers expect a special dividend payment?
Reading Knight Therapeutics' results and conference call recap, I learned Knight now has 700 employees, will have over $400M in cash after paying out all shareholders to conclude the purchase, concluded the battle with Medison, started expanding into Mexico on day one in December and does not foresee any financial stress on the company due to the virus. This is very positive. On the negative side, they obviously have a problem getting to Doctors although the flow of medicine is uninterrupted, two drugs were not designated for public funding by Health Canada and, obviously, the timing of the purchase would have most likely been better if done a couple of months later after the virus hit.
A couple of questions: would Knight have any options with the drugs refused public insurance or are they stuck with these investments and how much will that affect their business; do you think Knight will be able to use their vast international network to bring new drugs to Biotoscan that they may not have had access to; how much will the virus interfere with revenues in Canada, Israel and LatAm or will shipments continue as usual; and, finally, in general, do you think Knight, all situations considered, is on a positive trajectory for the future when the current crisis ends?
Thank you very much.
Read Answer Asked by Steven on April 02, 2020
Q: For those of us who still have Covalon shares, should we hold on to see if their product does have some promise? Or should we sell into strength. At one point, back pre-Saudi problems, you seemed to be very positive on the company: I had assumed you had a feeling for management and financial strength. Now, reading between the lines, you seem to be implying it is somewhat akin to a VSE mining stock promotion. (Maybe that's not a fair statement.) When I look at the product Covalon originally had regarding anti-infection of wounds, it makes some sense that they could pivot to something that might kill a virus. I understand that it would include sufficient alcohol to do the job, so is comparable to Purell. But they claim to have made something that would last longer than a simple alcohol wipe. I hear you say it is interesting, but I'm not quite sure how to take the fact that they were asked to re-write a somewhat promotional news release. Should we sell and then return when the product is more developed, or just hold for now?
Read Answer Asked by Gordon on April 01, 2020
Q: Hello 5i Team
Are there any restrictions to the percentage of foreign equity within a RRSP? From everything I have seen so far with the merger of TSGI The Stars Group and Flutter will be OK in terms of if I can hold a UK stock in our SpousalRRSP but will it matter that it is over 10% of that account (not of all combined accounts)? I really do not want to sell it as it has not performed and I still have faith in it.
Thank you
Jeremy
Read Answer Asked by Jeremy on March 31, 2020